For securitisation market participants, a key change is an amendment to Article 14 of CRR and its effect on the application of key obligations in the …
Check Also
Rebuttal To A Bearish Article About Amarin
Confusion remains about Amarin’s blockbuster trial results for its cardiovascular protection drug, Vascepa. A recent …